Feb22 event *remove after event end

Gain Therapeutics' 2024 R&D update with KOL and Analyst Insight

Register Here >>

subpage banner

Investor Resources

investor
resources

Contact IR

GAIN THERAPEUTICS INC.

 

4800 Montgomery Lane Ste
220 Bethesda, MD 20814,

 

ic_call_24px

+1 301 500 1556

Alerts Sign up

This form was created by ChronoForms

FAQs

Where are the headquarters of Gain Therapeutics, Inc. located?

 

4800 Hampden Ln, St 200
Bethesda, MD 20814, United States
(301) 500-1556

When was Gain Therapeutics, Inc. incorporated?

 

June 26, 2020

Where is Gain Therapeutics, Inc. incorporated?

 

Delaware

What is the stock symbol for Gain Therapeutics, Inc?

 

Our common stock is listed on the NASDAQ under the symbol “GANX”

When did Gain Therapeutics, Inc. become a public company?

 

March 18, 2021

When is Gain Therapeutics, Inc.’s fiscal year end?

 

December 31st

May I purchase stock directly from Gain Therapeutics, Inc?

 

No, you will need to contact a licensed financial advisor or use an online trading account.

Who is the transfer agent for Gain Therapeutics, Inc?

 

Pacific Stock Transfer, Inc. 2320 Haverford Rd. Suite 230 Ardmore, PA 19003

Who is the independent auditor for Gain Therapeutics, Inc?

 

Ernst & Young AG
Lancy-Geneva, Switzerland

How do I access copies of Gain Therapeutics, Inc.’s Annual Report or any other SEC filings?

 

Gain Therapeutics, Inc.’s SEC filings can be found on www.sec.gov and are also available under the “SEC Filings” page located in the “Investors” section of our corporate website.

How can I sign up to receive Gain Therapeutics, Inc. press releases and other company information?

 

Please sign up here to be added to the Gain Therapeutics, Inc. distribution list.

Who may I contact regarding investor inquiries?

 

This email address is being protected from spambots. You need JavaScript enabled to view it.